Cargando…

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma

BACKGROUND: Long noncoding RNAs (lncRNAs) are reported to play important roles in tumorigenesis of various malignant tumors. However, the clinical significance of aberrant lncRNA expression in hepatocellular carcinoma (HCC) is still elusive. METHODS: Firstly, a differentially expressed lncRNA CTC‐29...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Sicong, Huang, Xuelian, Zhang, Kelin, Tan, Wenliang, Lin, Zhirong, He, Qing, Chen, Yajin, Shang, Changzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912069/ https://www.ncbi.nlm.nih.gov/pubmed/31674731 http://dx.doi.org/10.1002/cam4.2618

Ejemplares similares

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection
por: Zhu, Sicong, et al.
Publicado: (2018)

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
por: Tan, Wenliang, et al.
Publicado: (2022)

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
por: Tan, Wenliang, et al.
Publicado: (2021)

miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression
por: Chen, Xianqing, et al.
Publicado: (2019)

Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway
por: Tan, Wenliang, et al.
Publicado: (2017)

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
por: Tan, Wenliang, et al.
Publicado: (2018)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Qingbin, et al.
Publicado: (2023)

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
por: Tan, Wenliang, et al.
Publicado: (2022)

A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma
por: Chen, Jie, et al.
Publicado: (2020)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

Molecular mechanisms of circular RNAs, transforming growth factor‐β, and long noncoding RNAs in hepatocellular carcinoma
por: Shang, Wenkang, et al.
Publicado: (2019)

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

High CTC-TRPC5 Expression Significantly Associated With Poor Prognosis in Radical Resected Colorectal Cancer Patients
por: Cai, Dongyan, et al.
Publicado: (2021)

297. Lactobacillus: Friend or Foe
por: Nwanyanwu, Chiemeziem, et al.
Publicado: (2020)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway
por: Yang, Lei, et al.
Publicado: (2022)

Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma
por: Zhu, Lei, et al.
Publicado: (2018)

The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer
por: Pan, Zhiwen, et al.
Publicado: (2016)

PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer
por: Zhang, Min, et al.
Publicado: (2020)

Evaluation of the diagnostic value of circulating tumor cells with CytoSorter(®) CTC capture system in patients with breast cancer
por: Jin, Lidan, et al.
Publicado: (2020)

A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
por: Cui, Hongxia, et al.
Publicado: (2017)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis
por: Chen, Weiwei, et al.
Publicado: (2021)

Health Tract, No. 297: Brain Work
Publicado: (1867)

Aneuploid CTC and CEC
por: Lin, Peter Ping
Publicado: (2018)

Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A
por: He, Jinyu, et al.
Publicado: (2019)

Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer
por: Yang, Song, et al.
Publicado: (2020)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma
por: Sun, Yu, et al.
Publicado: (2017)

ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
por: Wu, Chuan, et al.
Publicado: (2018)

297. Risk Factors for Infections in Open Fractures
por: Reisfeld, Sharon, et al.
Publicado: (2018)

High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis
por: Fang, Shi Xu, et al.
Publicado: (2020)

Magnetic Particles for CTC Enrichment
por: Liu, Peng, et al.
Publicado: (2020)

Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation
por: Pipatwatcharadate, Chawapon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_glqda4hqmosb9crsj2l2d80kte